2018 Clinical Trials DEA History 
Canna Law Blog
JANUARY 3, 2023
A little CBD history. Until recently, CBD resided in a legal penumbra where hemp was still scheduled on the federal Controlled Substances Act and could not be cultivated without a permit from the Drug Enforcement Administration (“DEA”). 2018 Farm Bill. The 2018 Farm Bill didn’t regulate CBD though.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 9, 2021
Beginning in 2018, the FDA has started to grant special designations to study the medicinal use of psilocybin via Breakthrough Therapy status. Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way.
SpeedWeed
DECEMBER 28, 2018
In my defense, 2018 has been a wild ride in the world of weed, a 12-month timespan which truly could be called “the best of times and the worst of times,” or perhaps just the highest and lowest of times. The Top 10 Cannabis Stories of 2018. But until then, here are the buzzes and bummers 2018 had to offer.
Cannabis Law Report
MARCH 2, 2020
In 2018, the U.S. This landmark approval is unique in that ketamine is well known to have hallucinogenic properties, as well as a long history as a party drug. Any approved medicines will have to be rescheduled by the Drug Enforcement Administration (DEA). Then, something strange happened. Potential IPOs within the next year.
Cannabis Law Report
FEBRUARY 28, 2022
Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. Patents on psychedelics raise unique concerns associated with their unusual qualities, history, and regulation. Trial of Psilocybin Versus Escitalopram for Depression , 384 NEW ENG. Mitchell et al.,
Cannabis Law Report
MARCH 21, 2019
On December 12, 2018 Congress passed the 2018 Farm Bill that removed hemp-derived products from the Schedule 1 list under the Controlled Substances Act. Although the DEA refuses to remove marijuana from the schedule 1 list, the Farm Bill is considered to be the most important victory in the history of U.S.
Expert insights. Personalized for you.
75 
Let's personalize your content